{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:11:58Z","timestamp":1789056718475,"version":"build-2803163510"},"reference-count":24,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science and Technology Project","award":["2025HY0398"],"award-info":[{"award-number":["2025HY0398"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Percutaneous intramyocardial septal radiofrequency ablation (PIMSRA), also known as the Liwen procedure, is an emerging septal reduction therapy for obstructive hypertrophic cardiomyopathy (OHCM), but standardized early rehabilitation pathways after PIMSRA are lacking. We aimed to develop an enhanced recovery after surgery (ERAS)-informed, risk-stratified stepwise rehabilitation pathway after PIMSRA, describe its documented early inpatient implementation in selected clinically stable patients, report preliminary in-hospital safety observations, and explore its associations with hospitalization outcomes. Methods: This exploratory single-center retrospective cohort study included 102 patients with OHCM who underwent first-time PIMSRA between 1 July 2023 and 3 August 2025 and met the same predefined post-PIMSRA rehabilitation eligibility criteria. Patients were classified according to the care pathway actually received: usual care (n = 53) or early inpatient implementation of the ERAS-informed rehabilitation pathway plus usual care (n = 49). The planned pathway incorporated rehabilitation eligibility screening, risk stratification, staged early mobilization, structured physiological monitoring with predefined stop criteria, multidisciplinary coordination, and patient education. Pathway selection was nonrandomized and reflected patient- or family-related preferences and implementation or logistical factors. Results: The ERAS-informed group had a shorter ICU length of stay than the usual-care group in the primary analysis [20.0 (5.8\u201326.6) h vs. 23.0 (17.1\u201345.5) h; Hodges\u2013Lehmann difference, \u22126.0 h; 95% CI, \u221216.51 to \u22120.53; p = 0.022]. Three ICU stays &gt; 100 h occurred in the usual-care group and none in the ERAS-informed group; after excluding these observations, the comparison was attenuated (p = 0.060). The total hospital length of stay was shorter in the ERAS-informed group [8.0 (7.0\u201311.0) d vs. 9.0 (8.0\u201313.0) d; difference, \u22121.0 d; 95% CI, \u22122.02 to \u22120.03; p = 0.029], whereas the post-PIMSRA length of stay did not differ significantly (p = 0.058). The admission-to-PIMSRA interval was also not significantly different (p = 0.309). No rehabilitation-related adverse events were recorded in the ERAS-informed group during hospitalization (0\/49; exact binomial 95% CI, 0.0\u20137.3%). Conclusions: Among selected clinically stable patients after PIMSRA, early inpatient implementation of pathway components was achievable, primarily during the period corresponding to planned stages 1\u20132. No rehabilitation-related adverse events were recorded, providing preliminary patient-level in-hospital safety observations. Fidelity, adherence, completion, and reproducibility of the complete four-stage, risk-stratified pathway were not established. Length-of-stay associations were exploratory and should not be interpreted causally.<\/jats:p>","DOI":"10.3390\/jcm15187029","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:54:19Z","timestamp":1789055659000},"page":"7029","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Inpatient Implementation of an ERAS-Informed Stepwise Rehabilitation Pathway After Percutaneous Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8560-5681","authenticated-orcid":false,"given":"Danyan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Boren","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou 310009, China"},{"name":"Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou 310009, China"},{"name":"Transvascular Implantation Devices Research Institute, Hangzhou 310053, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-1838","authenticated-orcid":false,"given":"Qifeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou 310009, China"},{"name":"Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou 310009, China"},{"name":"Transvascular Implantation Devices Research Institute, Hangzhou 310053, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Huajun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou 310009, China"},{"name":"Heart Regeneration and Repair Key Laboratory of Zhejiang Province, Hangzhou 310009, China"},{"name":"Transvascular Implantation Devices Research Institute, Hangzhou 310053, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6350-089X","authenticated-orcid":false,"given":"Yue","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: A report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2020.01.021","article-title":"Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team","volume":"304","author":"Pelliccia","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.124.069378","article-title":"Long-term outcomes after septal reduction therapies in obstructive hypertrophic cardiomyopathy: Insights from the SHARE Registry","volume":"150","author":"Maurizi","year":"2024","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jacc.2018.07.080","article-title":"Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy","volume":"72","author":"Liu","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamacardio.2022.0259","article-title":"Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy","volume":"7","author":"Zhou","year":"2022","journal-title":"JAMA Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/heartjnl-2023-323606","article-title":"Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up","volume":"110","author":"Ta","year":"2024","journal-title":"Heart"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/heartjnl-2022-321597","article-title":"Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation","volume":"109","author":"Li","year":"2023","journal-title":"Heart"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13019-024-02934-1","article-title":"Analysis of risk factors for complications in echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation","volume":"19","author":"Wang","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_12","first-page":"1096","article-title":"Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: An updated comprehensive review and meta-analysis","volume":"104","author":"Sanches","year":"2024","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Osama, M., Ubaid, S., Ali, M.A., Majid, A., Khan, L.A., Khan, A., Abideen, Z.U., Waseem, M.H., Ubaid, M., and Ahmed, R. (2025). Efficacy and safety of percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis. Cardiol. Rev.","DOI":"10.1097\/CRD.0000000000001050"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1136\/heartjnl-2021-319861","article-title":"Exercise prescription in individuals with hypertrophic cardiomyopathy: What clinicians need to know","volume":"108","author":"Gati","year":"2022","journal-title":"Heart"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2017.2503","article-title":"Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: A randomized clinical trial","volume":"317","author":"Saberi","year":"2017","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2047487313501277","article-title":"Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: Results of a structured exercise training program in a cardiac rehabilitation center","volume":"22","author":"Klempfner","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jamacardio.2023.1042","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"8","author":"Lampert","year":"2023","journal-title":"JAMA Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/eurheartj\/ehae919","article-title":"High intensity exercise programme in patients with hypertrophic cardiomyopathy: A randomized trial","volume":"46","author":"Basu","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamasurg.2019.1153","article-title":"Guidelines for perioperative care in cardiac surgery: Enhanced Recovery After Surgery Society recommendations","volume":"154","author":"Engelman","year":"2019","journal-title":"JAMA Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.athoracsur.2021.06.072","article-title":"Cardiac enhanced recovery after surgery: Early outcomes in a community setting","volume":"113","author":"Salenger","year":"2022","journal-title":"Ann. Thorac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.21470\/1678-9741-2021-0140","article-title":"Early mobilization prescription in patients undergoing cardiac surgery: Systematic review","volume":"37","author":"Borges","year":"2022","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kanejima, Y., Shimogai, T., Kitamura, M., Ishihara, K., and Izawa, K.P. (2020). Effect of early mobilization on physical function in patients after cardiac surgery: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17197091"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1177\/2047487319898106","article-title":"Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy","volume":"27","author":"Smith","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ehjci\/jeab001","article-title":"Impact of left atrial strain mechanics on exercise intolerance and need for septal reduction therapy in hypertrophic cardiomyopathy","volume":"23","author":"Saijo","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7029\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:03:59Z","timestamp":1789056239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":24,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187029"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187029","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}